search
Login
In the Spotlight About
search

Menu

Home Watchlists Categories Smart Screener Newsletter About Login Sign Up

Scientific Industries, Inc. (SCND)

—
$0.57
+0.00 (0.00%)
Get curated updates for this stock by email. We filter for the most important fundamentals-focused developments and send only the key news to your inbox.

Data provided by IEX. Delayed 15 minutes.

Market Cap

$6.7M

Enterprise Value

$-797.5K

P/E Ratio

N/A

Div Yield

0.00%

Rev Growth YoY

-3.6%

Rev 3Y CAGR

+3.1%

Earnings 3Y CAGR

+20.6%

Scientific Industries: Betting On Biotech Sensors And Pharmacy Automation For Future Growth (SCND)

By BeyondSPX Research | Published on June 18, 2025

Scientific Industries (SCND) is a US-based company transitioning from traditional benchtop lab equipment to a growth-focused life sciences firm. Its main businesses are Bioprocessing Systems (DOTS platform) and Torbal automated pharmacy solutions, targeting high-margin, recurring revenue.

Executive Summary / Key Takeaways

  • Scientific Industries (SCND) is undergoing a strategic transformation, shifting from a mature benchtop lab equipment provider to a growth-oriented life sciences company focused on high-margin, recurring revenue streams through its Bioprocessing Systems and Torbal automated pharmacy businesses.
  • The company's core investment thesis hinges on the successful commercialization and market adoption of its innovative DOTS platform for digitally simplified bioprocessing and the VIVID line of automated pill counters, particularly the newly launched Multi Parameter Sensor and Workstation models.
  • Recent financial results for Q1 2025 show continued operating losses ($1.81M) and negative cash flow from operations ($1.33M), reflecting ongoing investment in growth initiatives and highlighting liquidity challenges, necessitating recent financing activities.
  • SCND faces significant competition from large, established players like Thermo Fisher Scientific (TMO), Danaher Corporation (DHR), and Agilent Technologies (A), but aims to differentiate through niche technological advantages, ease of use, and addressing specific unmet needs in underserved market segments.
  • Management is targeting a return to profitability and positive cash flow within 24 months, contingent on achieving market acceptance for new products, scaling recurring revenue from software subscriptions and consumables, and realizing cost efficiencies from recent operational restructuring.

The Transformation Story: From Benchtop Staples to Biotech Ambitions

For decades, Scientific Industries, Inc. (SCND) built its reputation on reliable, if somewhat mature, benchtop laboratory equipment, epitomized

Disclaimer: This report is for informational purposes only and does not constitute financial advice, investment advice, or any other type of advice. The information provided should not be relied upon for making investment decisions. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.

Get Curated Fundamental Updates for — Free Forever

We filter for the most important fundamentals-focused developments and send only the key news to your inbox.

or
Free forever. No credit card. No spam.
Already have an account? Sign in.